- Open Access
Soluble histone H2AX is induced by DNA replication stress and sensitizes cells to undergo apoptosis
© Liu et al; licensee BioMed Central Ltd. 2008
Received: 01 May 2008
Accepted: 10 July 2008
Published: 10 July 2008
Chromatin-associated histone H2AX is a key regulator of the cellular responses to DNA damage. However, non-nucleosomal functions of histone H2AX are poorly characterized. We have recently shown that soluble H2AX can trigger apoptosis but the mechanisms leading to non-chromatin-associated H2AX are unclear. Here, we tested whether stalling of DNA replication, a common event in cancer cells and the underlying mechanism of various chemotherapeutic agents, can trigger increased soluble H2AX.
Transient overexpression of H2AX was found to lead to a detectable fraction of soluble H2AX and was associated with increased apoptosis. This effect was enhanced by the induction of DNA replication stress using the DNA polymerase α inhibitor aphidicolin. Cells manipulated to stably express H2AX did not contain soluble H2AX, however, short-term treatment with aphidicolin (1 h) resulted in detectable amounts of H2AX in the soluble nuclear fraction and enhanced apoptosis. Similarly, soluble endogenous H2AX was detected under these conditions. We found that excessive soluble H2AX causes chromatin aggregation and inhibition of ongoing gene transcription as evidenced by the redistribution and/or loss of active RNA polymerase II as well as the transcriptional co-activators CBP and p300.
Taken together, these results show that DNA replication stress rapidly leads to increased soluble H2AX and that non-chromatin-associated H2AX can sensitize cells to undergo apoptosis. Our findings encourage further studies to explore H2AX and the cellular pathways that control its expression as anti-cancer drug targets.
Chromatin-associated histone H2AX is a key regulator of the cellular response to genotoxic stress and DNA double-strand breaks [1–6]. H2AX is a core histone H2A variant that is randomly incorporated into nucleosomes during DNA replication. It differs from histone H2A by a unique C-terminal tail that contains a highly conserved SQE motif with a serine residue at position 139 . Serine 139 becomes rapidly phosphorylated in response to DNA double strand breaks by protein kinases of the phosphatidylinositol 3-OH-kinase-related kinase (PI3KK) family including ATM, ATR or DNA-PK [8–10]. The phosphorylated form of H2AX has been referred to as γ-H2AX . Several lines of evidence suggest that the main function of histone H2AX is to orchestrate the DNA damage response through interactions with BRCT repeat-containing proteins that bind phosphorylated H2AX such as MDC1 [11–13]. However, H2AX has also been implicated in a number of other functions including inactivation of sex chromosomes and control of sister chromatid recombination [14, 15]. We have recently shown that histone H2AX also has non-nucleosomal functions, specifically, pro-apoptotic activities in gastrointestinal stromal tumor (GIST) cells treated with the small molecule protein kinase inhibitor imatinib mesylate (Gleevec) .
Previous studies in yeast have shown that histone levels need to be tightly regulated and that high levels of non-chromatin bound histones are cytotoxic . Soluble histones can accumulate when DNA replication and histone incorporation into the newly synthesized chromatin become uncoupled, for example after stalling of replication forks [17–19].
The present study was designed to determine the mechanisms that lead to increased soluble H2AX. We found that even short-term stalling of replication forks is sufficient to cause an increase of soluble H2AX. Furthermore, we show that transient overexpression of H2AX, but not H2A, promotes apoptotic cell death. In addition, we demonstrate that overexpression of H2AX leads to a nuclear redistribution and/or loss of the active form of RNA polymerase II as well as the transcriptional co-activators CBP and p300. Taken together, our results suggest a model in which replication stress leads to increased soluble H2AX, which sensitize cells to undergo apoptosis in a process that involves a shut-down of gene transcription.
Replication stress induces soluble H2AX
To further corroborate our results, U-2 OS cell populations stably expressing GFP-tagged H2AX, H2AX-S139A or empty vector were generated. In stable cell populations, H2AX was undetectable in S3 fractions from untreated cells (Fig. 1C). However, treatment with aphidicolin for 1 h rapidly resulted in an increase of soluble H2AX and H2AX-S139A (Fig. 1C; S3 fractions).
Taken together, these results show that transient stalling of DNA replication forks is associated with an increase of soluble histone H2AX.
Overexpression of H2AX sensitizes cells to undergo apoptosis
To determine whether replication stress sensitizes H2AX-overexpressing cells to undergo apoptosis, we used U-2 OS cell populations stably expressing either empty GFP vector, GFP-tagged H2AX or GFP-H2AX-S139A. Cells were treated with aphidicolin for 24 h and the proportion of apoptotic cells was assessed (Fig. 2C). A significant 2.2-fold increase of apoptotic U-2 OS cells stably expressing GFP-H2AX was detected from 4.5% in DMSO-treated controls to 9.7% in aphidicolin-treated populations (p ≤ 0.05). In addition, a significant 9.2-fold increase of apoptotic cells was detected in U-2 OS cells stably expressing GFP-H2AX-S139A from 0.5% in DMSO-treated controls to 4.6% in aphidicolin-treated cells (p ≤ 0.0001). No apoptotic cells were found in populations expressing empty GFP vector, regardless of the drug treatment (Fig. 2C).
We tested next whether overexpression of core histone H2A was able to stimulate apoptosis. Transiently transfected cell populations were stained with an anti-myc-tag antibody and assessed for apoptotic nuclear morphology. The proportion of transfected cells was similar to H2AX-transfected populations. No enhanced cell death was detected when myc-tagged H2A was overexpressed under transient conditions in comparison to empty myc-tag vector (Fig. 2D,E).
Taken together, these results indicate that overexpression of histone H2AX, but not histone H2A, can sensitize cells to undergo apoptosis.
Overexpression of H2AX causes chromatin aggregation
Overexpression of histone H2AX is associated with a redistribution of components of the transcriptional machinery
We detected a significant increase of cells with redistribution of pRNA pol II S2 into nuclear speckles or loss of pRNA pol II S2 expression below detection level by immunofluorescence microscopy in cells ectopically expressing H2AX (2.9-fold; 36.5%; p ≤ 0.05) or H2AX-S139A (2.7-fold; 34.2%; p ≤ 0.005) when compared to controls (12.5%; Fig. 4A,B). In the vast majority of these cells, nuclear redistribution of RNA pol II S2 coincided with chromatin aggregation (Fig. 4A; middle panels). No significant effect on pRNA pol II S2 distribution was detected when H2A-transfected cells were analyzed (Fig. 4A,B). In addition to pRNA pol II S2, we found the transcriptional co-activator CBP to be displaced from chromatin in cells transfected either with H2AX (3.2-fold increase, 36%; p ≤ 0.05) or H2AX-S139A (2.1-fold increase, 24%; p ≤ 0.01) in comparison to empty vector controls (11.4%; Fig. 4D,E). Similar results were found when cells were analyzed for expression of p300 (Fig. 4F). Furthermore, pRNA pol II S2 was displaced from chromatin after treatment with aphidicolin as shown by immunoblotting further corroborating the results obtained by immunofluorescence staining (Fig. 4G). Since transcription is required for cell viability, our results suggest that the ability of H2AX to abrogate ongoing transcription may sensitize cells to undergo apoptosis.
Histone variant H2AX plays a pivotal role in the maintenance of genome stability, in particular in the absence of p53 [1, 6, 28]. We have previously shown that soluble histone H2AX is involved in apoptosis induction in GIST cells treated with the small molecule inhibitor imatinib mesylate . Here, we extend these results by showing DNA replication stress as one mechanism that can lead to an increase of the pool of soluble H2AX. We show that overexpression of H2AX sensitizes cells to apoptosis in a process that is associated with a disruption of ongoing gene transcription as evidenced by a redistribution of active RNA pol II as well as CBP and p300.
Our report raises a number of questions that warrant further investigation. First, it is unclear why the overall level of apoptosis in U-2 OS after transient overexpression of H2AX is comparatively low (in the range of 5%) in comparison to GIST cells (approximately 40%) . One possibility is that GIST cells are particularly sensitive to increased non-chromatin associated H2AX because they express oncogenic KIT. We have previously speculated that KIT may constitutively downregulate H2AX, which may render GIST cells particularly sensitive to its re-expression (see also below). Second, despite our current results the precise mechanisms that lead to soluble H2AX remain unclear. Since the reagents used here induce stalling of DNA replication forks, it is possible that the uncoupling of histone production and histone incorporation into chromatin leads to excessive levels of free histones as it has previously been suggested [17–19]. However, prolonged replication arrest can also cause DNA breakage and hence the possibility that increased soluble H2AX is a result of accelerated histone eviction during DNA damage-associated chromatin reorganization cannot be dismissed . Third, the precise mechanisms of apoptosis induction by histone H2AX await further clarification. Our results suggest that chromatin aggregation and transcriptional shut down, which cannot be sustained for a prolonged period of time without affecting cell viability, are important. However, this is a relatively non-specific mechanism and other, more direct, pro-apoptotic mechanisms of H2AX may also be involved . Although we cannot rule out the possibility that release of histones from cells undergoing apoptosis contributes to a certain degree to the increase of soluble H2AX , the present report provides additional evidence that soluble histone H2AX is a cause for increased cell death and not simply a consequence.
It is conceivable that replication stress is a frequent event in tumor cells [32, 33]. Given the potentially deleterious consequences of excessive H2AX [16, 17], one prediction would be that mechanisms exist that regulate the pool of non-chromatin-associated H2AX. Such mechanisms are likely to involve the ubiquitin/proteasome machinery since we have previously shown that H2AX can become polyubiquitinated and that proteasome inhibition can stabilize H2AX . Recent findings show that the ubiquitin-conjugating enzyme Ubc13 and the RING-finger ubiquitin ligase RNF8 are involved in DNA damage-induced H2AX ubiquitination [34–38]. Whether these proteins are also involved in the modulation of H2AX levels in tumor cells remains to be tested.
The fact that soluble H2AX induces apoptosis in tumor cells opens new avenues for cancer therapy. Identification of drugs that induce soluble H2AX, e.g. by inhibiting a potential suppressor of H2AX, would be promising. Given the role of the ubiquitin-proteasome system in the regulation of H2AX levels in GISTs , it is also conceivable that targeting the protein degradation machinery could lead to increased soluble H2AX levels. Furthermore, the GFP-tagged H2AX vectors could be used in a compound screen with chromatin aggregation as the readout.
In summary, we report here that DNA replication stress rapidly leads to an increase of soluble H2AX. Overexpression of H2AX was found to sensitize cells to undergo apoptosis, which very likely involves the disruption of ongoing gene transcription. Our findings encourage further studies to exploit H2AX and the cellular mechanisms that regulate its expression levels as novel anti-cancer drug targets.
This report shows that stalling of DNA replication leads to an increase of soluble H2AX in human tumor cells. Soluble H2AX was found to sensitize cells to undergo apoptosis and this activity was associated with a transcriptional shut-down. These results encourage further studies to exploit histone H2AX and the mechanisms that regulate its expression as anti-cancer drug targets.
Materials and methods
Cell culture and transfections
U-2 OS osteosarcoma cells and H1299 lung cancer cells were obtained from ATCC (Manassas, VA) and maintained in Dulbecco's modified Eagle medium (DMEM; Cambrex, Baltimore, MD) supplemented with 10% fetal bovine serum (FBS; Mediatech, Herndon, VA), 50 U/ml penicillin and 50 μg/ml streptomycin (both BioWhittaker, Baltimore, MD). Cells were transfected with an empty GFP vector or N-terminal GFP fusion plasmids encoding wild-type H2AX and H2AX in which serine 139 has been substituted by alanine (H2AX-S139A) using Fugene 6 (Invitrogen, Carlsbad, CA). In addition, empty myc-tag vector or myc-H2A was used for transient overexpression experiments. Stable cell populations were generated by selecting cells in G418-containing media for 48 h.
Whole cell lysates were prepared by scraping cells into RIPA buffer (1% NP-40, 50 mM Tris-HCl pH 8.0, 100 mM sodium fluoride, 30 mM sodium pyrophosphate, 2 mM sodium molybdate, 5 mM EDTA, 2 mM sodium orthovanadate) containing protease inhibitors (10 μg/ml aprotinin, 10 μg/ml leupeptin, 1 μM phenylmethylsulfonyl fluoride). Suspensions were incubated for one hour at 4°C and cleared by centrifugation for 30 min at 14,000 rpm at 4°C. Protein concentrations were determined by the Bradford assay (Biorad, Hercules, CA). 30 μg of protein were loaded on a 4–12% Bis-Tris gel (Invitrogen, Carlsbad, CA) and blotted onto a nitrocellulose membrane. Primary antibodies used were directed against GFP (Lab Vision, Fremont, CA), H2AX (Bethyl Laboratories, Montgomery, TX), ORC2 (BD Biosciences Pharmingen), phosphorylated RNA pol II S2 (Covance, Berkeley, CA) and actin (Sigma, St. Louis, MS).
For immunofluorescence micoscopic analyses, cells were grown on coverslips, washed in PBS, fixed in 4% paraformaldehyde/PBS (15 min), permeabilized with 1% Triton-X 100/PBS (15 min) and blocked in 10% normal donkey serum (Jackson Immunoresearch, West Grove, PA) for 15 min at room temperature. After incubation with primary antibodies overnight at 4°C in a humid chamber, cells were incubated with FITC-conjugated or Rhodamine Red-conjugated secondary antibodies (Jackson Immunoresearch, 2 hours at 37°C) and counterstained with DAPI (Vector Laboratories, Burlingame, CA). For double-immunofluorescence analysis, cells were stained for the first antigen followed by a second primary antibody and an AMCA-labeled secondary antibody (Jackson Immunoresearch). Primary antibodies used for immunofluorescence stainings were directed against γ-H2AX (Trevigen, Gaithersburg, MD), myc-tag (Cell Signaling, Danvers, MA), phosphorylated RNA pol II S2 (Covance, Berkeley, CA), CBP and p300 (both Santa Cruz, Santa Cruz, CA). Cells were analyzed using an Olympus AX70 epifluorescence microscope equipped with a SpotRT digital camera.
Subcellular fractionation was performed according to Mendez and Stillman . Cells were trypsinized, collected by centrifugation, washed with PBS, resuspended in Buffer A (10 mM HEPES, pH 7.9, 10 mM KCl, 1.5 mM MgCl2, 10 mM NaF, 340 mM sucrose, 10% glycerol, 1 mM DTT, 0.1 mM PMSF, 1 mM sodium orthovanadate, 0.1% Triton-X 100, 5 μg/ml leupeptin 5 μg/ml aprotinin) and incubated on ice for 5 minutes. The nuclei (P1) were collected by low speed centrifugation at 1,300 g and lysed in Buffer B (3 mM EDTA, 0.2 mM EGTA, 1 mM DTT, 0.1 mM PMSF, 1 mM sodium orthovanadate, 5 μg/ml leupeptin, 5 μg/ml aprotinin) for 10 minutes on ice. The insoluble chromatin fraction (P3) was collected by centrifugation at 1,700 g. The supernatant contained the soluble nuclear proteins (S3). The chromatin pellet (P3) was resuspended in SDS sample buffer and the DNA was sheared by sonication in a 550 Sonic Dismembrator (Fisher) at 15% amplitude.
Apoptotic cells were visualized using the In Situ Cell Death Detection Kit (Roche Applied Sciences, Indianapolis, IN) according to manufacturer's instructions.
Statistical significance was assessed using Student's t test for independent samples. P values ≤ 0.05 were considered significant.
We are grateful to Joseph S. Siino (University of California Davis School of Medicine, Davis, CA) and Nicolai Tomilin (Institute of Cytology, Russian Academy of Sciences, St. Petersburg, Russia) for the GFP-H2AX and GFP-H2AX-S139A constructs and Brian Chadwick and Huntington F. Willard (Institute for Genome Sciences & Policy, Duke University, Durham, NC) for the H2A plasmid. This work was supported by the GIST Cancer Research Fund (GCRF), numerous private donations and a Research Scholar Grant from the American Cancer Society to A.D. (RSG-08-092-01-CCG).
- Bassing CH, Chua KF, Sekiguchi J, Suh H, Whitlow SR, Fleming JC, Monroe BC, Ciccone DN, Yan C, Vlasakova K, Livingston DM, Ferguson DO, Scully R, Alt FW: Increased ionizing radiation sensitivity and genomic instability in the absence of histone H2AX. Proc Natl Acad Sci U S A. 2002, 99: 8173-8178. 10.1073/pnas.122228699PubMed CentralView ArticlePubMedGoogle Scholar
- Rogakou EP, Pilch DR, Orr AH, Ivanova VS, Bonner WM: DNA double-stranded breaks induce histone H2AX phosphorylation on serine 139. J Biol Chem. 1998, 273: 5858-5868. 10.1074/jbc.273.10.5858View ArticlePubMedGoogle Scholar
- Sedelnikova OA, Pilch DR, Redon C, Bonner WM: Histone H2AX in DNA damage and repair. Cancer Biol Ther. 2003, 2: 233-235.View ArticlePubMedGoogle Scholar
- Fernandez-Capetillo O, Lee A, Nussenzweig M, Nussenzweig A: H2AX: the histone guardian of the genome. DNA Repair (Amst). 2004, 3: 959-967. 10.1016/j.dnarep.2004.03.024View ArticleGoogle Scholar
- Celeste A, Difilippantonio S, Difilippantonio MJ, Fernandez-Capetillo O, Pilch DR, Sedelnikova OA, Eckhaus M, Ried T, Bonner WM, Nussenzweig A: H2AX haploinsufficiency modifies genomic stability and tumor susceptibility. Cell. 2003, 114: 371-383. 10.1016/S0092-8674(03)00567-1View ArticlePubMedGoogle Scholar
- Celeste A, Petersen S, Romanienko PJ, Fernandez-Capetillo O, Chen HT, Sedelnikova OA, Reina-San-Martin B, Coppola V, Meffre E, Difilippantonio MJ, Redon C, Pilch DR, Olaru A, Eckhaus M, Camerini-Otero RD, Tessarollo L, Livak F, Manova K, Bonner WM, Nussenzweig MC, Nussenzweig A: Genomic instability in mice lacking histone H2AX. Science. 2002, 296: 922-927. 10.1126/science.1069398View ArticlePubMedGoogle Scholar
- Redon C, Pilch D, Rogakou E, Sedelnikova O, Newrock K, Bonner W: Histone H2A variants H2AX and H2AZ. Curr Opin Genet Dev. 2002, 12: 162-169. 10.1016/S0959-437X(02)00282-4View ArticlePubMedGoogle Scholar
- Burma S, Chen BP, Murphy M, Kurimasa A, Chen DJ: ATM phosphorylates histone H2AX in response to DNA double-strand breaks. J Biol Chem. 2001, 276: 42462-42467. 10.1074/jbc.C100466200View ArticlePubMedGoogle Scholar
- Ward IM, Chen J: Histone H2AX is phosphorylated in an ATR-dependent manner in response to replicational stress. J Biol Chem. 2001, 276: 47759-47762. 10.1074/jbc.M009785200View ArticlePubMedGoogle Scholar
- Park EJ, Chan DW, Park JH, Oettinger MA, Kwon J: DNA-PK is activated by nucleosomes and phosphorylates H2AX within the nucleosomes in an acetylation-dependent manner. Nucleic Acids Res. 2003, 31: 6819-6827. 10.1093/nar/gkg921PubMed CentralView ArticlePubMedGoogle Scholar
- Paull TT, Rogakou EP, Yamazaki V, Kirchgessner CU, Gellert M, Bonner WM: A critical role for histone H2AX in recruitment of repair factors to nuclear foci after DNA damage. Curr Biol. 2000, 10: 886-895. 10.1016/S0960-9822(00)00610-2View ArticlePubMedGoogle Scholar
- Celeste A, Fernandez-Capetillo O, Kruhlak MJ, Pilch DR, Staudt DW, Lee A, Bonner RF, Bonner WM, Nussenzweig A: Histone H2AX phosphorylation is dispensable for the initial recognition of DNA breaks. Nat Cell Biol. 2003, 5: 675-679. 10.1038/ncb1004View ArticlePubMedGoogle Scholar
- Stucki M, Clapperton JA, Mohammad D, Yaffe MB, Smerdon SJ, Jackson SP: MDC1 directly binds phosphorylated histone H2AX to regulate cellular responses to DNA double-strand breaks. Cell. 2005, 123: 1213-1226. 10.1016/j.cell.2005.09.038View ArticlePubMedGoogle Scholar
- Fernandez-Capetillo O, Mahadevaiah SK, Celeste A, Romanienko PJ, Camerini-Otero RD, Bonner WM, Manova K, Burgoyne P, Nussenzweig A: H2AX is required for chromatin remodeling and inactivation of sex chromosomes in male mouse meiosis. Dev Cell. 2003, 4: 497-508. 10.1016/S1534-5807(03)00093-5View ArticlePubMedGoogle Scholar
- Xie A, Puget N, Shim I, Odate S, Jarzyna I, Bassing CH, Alt FW, Scully R: Control of sister chromatid recombination by histone H2AX. Mol Cell. 2004, 16: 1017-1025. 10.1016/j.molcel.2004.12.007View ArticlePubMedGoogle Scholar
- Liu Y, Tseng M, Perdreau SA, Rossi F, Antonescu C, Besmer P, Fletcher JA, Duensing S, Duensing A: Histone H2AX is a mediator of gastrointestinal stromal tumor cell apoptosis following treatment with imatinib mesylate. Cancer Res. 2007, 67: 2685-2692. 10.1158/0008-5472.CAN-06-3497View ArticlePubMedGoogle Scholar
- Gunjan A, Verreault A: A Rad53 kinase-dependent surveillance mechanism that regulates histone protein levels in S. cerevisiae. Cell. 2003, 115: 537-549. 10.1016/S0092-8674(03)00896-1View ArticlePubMedGoogle Scholar
- Bonner WM, Wu RS, Panusz HT, Muneses C: Kinetics of accumulation and depletion of soluble newly synthesized histone in the reciprocal regulation of histone and DNA synthesis. Biochemistry. 1988, 27: 6542-6550. 10.1021/bi00417a052View ArticlePubMedGoogle Scholar
- Bonner WM, Mannironi C, Orr A, Pilch DR, Hatch CL: Histone H2A.X gene transcription is regulated differently than transcription of other replication-linked histone genes. Mol Cell Biol. 1993, 13: 984-992.PubMed CentralPubMedGoogle Scholar
- Siino JS, Nazarov IB, Svetlova MP, Solovjeva LV, Adamson RH, Zalenskaya IA, Yau PM, Bradbury EM, Tomilin NV: Photobleaching of GFP-labeled H2AX in chromatin: H2AX has low diffusional mobility in the nucleus. Biochem Biophys Res Commun. 2002, 297: 1318-1323. 10.1016/S0006-291X(02)02383-5View ArticlePubMedGoogle Scholar
- Steger DJ, Workman JL: Transcriptional analysis of purified histone acetyltransferase complexes. Methods. 1999, 19: 410-416. 10.1006/meth.1999.0877View ArticlePubMedGoogle Scholar
- Hahn S: Structure and mechanism of the RNA polymerase II transcription machinery. Nat Struct Mol Biol. 2004, 11: 394-403. 10.1038/nsmb763PubMed CentralView ArticlePubMedGoogle Scholar
- Jackson DA, Hassan AB, Errington RJ, Cook PR: Visualization of focal sites of transcription within human nuclei. Embo J. 1993, 12: 1059-1065.PubMed CentralPubMedGoogle Scholar
- Wansink DG, Schul W, van der Kraan I, van Steensel B, van Driel R, de Jong L: Fluorescent labeling of nascent RNA reveals transcription by RNA polymerase II in domains scattered throughout the nucleus. J Cell Biol. 1993, 122: 283-293. 10.1083/jcb.122.2.283View ArticlePubMedGoogle Scholar
- Janknecht R, Hunter T: Transcription. A growing coactivator network. Nature. 1996, 383: 22-23. 10.1038/383022a0View ArticlePubMedGoogle Scholar
- Lee KB, Wang D, Lippard SJ, Sharp PA: Transcription-coupled and DNA damage-dependent ubiquitination of RNA polymerase II in vitro. Proc Natl Acad Sci U S A. 2002, 99: 4239-4244. 10.1073/pnas.072068399PubMed CentralView ArticlePubMedGoogle Scholar
- von Mikecz A, Zhang S, Montminy M, Tan EM, Hemmerich P: CREB-binding protein (CBP)/p300 and RNA polymerase II colocalize in transcriptionally active domains in the nucleus. J Cell Biol. 2000, 150: 265-273. 10.1083/jcb.150.1.265PubMed CentralView ArticlePubMedGoogle Scholar
- Bassing CH, Suh H, Ferguson DO, Chua KF, Manis J, Eckersdorff M, Gleason M, Bronson R, Lee C, Alt FW: Histone H2AX: a dosage-dependent suppressor of oncogenic translocations and tumors. Cell. 2003, 114: 359-370. 10.1016/S0092-8674(03)00566-XView ArticlePubMedGoogle Scholar
- Ikura T, Tashiro S, Kakino A, Shima H, Jacob N, Amunugama R, Yoder K, Izumi S, Kuraoka I, Tanaka K, Kimura H, Ikura M, Nishikubo S, Ito T, Muto A, Miyagawa K, Takeda S, Fishel R, Igarashi K, Kamiya K: DNA damage-dependent acetylation and ubiquitination of H2AX enhances chromatin dynamics. Mol Cell Biol. 2007, 27: 7028-7040. 10.1128/MCB.00579-07PubMed CentralView ArticlePubMedGoogle Scholar
- Lu C, Zhu F, Cho YY, Tang F, Zykova T, Ma WY, Bode AM, Dong Z: Cell apoptosis: requirement of H2AX in DNA ladder formation, but not for the activation of caspase-3. Mol Cell. 2006, 23: 121-132. 10.1016/j.molcel.2006.05.023PubMed CentralView ArticlePubMedGoogle Scholar
- Wu D, Ingram A, Lahti JH, Mazza B, Grenet J, Kapoor A, Liu L, Kidd VJ, Tang D: Apoptotic release of histones from nucleosomes. J Biol Chem. 2002, 277: 12001-12008. 10.1074/jbc.M109219200View ArticlePubMedGoogle Scholar
- Bartkova J, Horejsi Z, Koed K, Kramer A, Tort F, Zieger K, Guldberg P, Sehested M, Nesland JM, Lukas C, Orntoft T, Lukas J, Bartek J: DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis. Nature. 2005, 434: 864-870. 10.1038/nature03482View ArticlePubMedGoogle Scholar
- Ekholm-Reed S, Mendez J, Tedesco D, Zetterberg A, Stillman B, Reed SI: Deregulation of cyclin E in human cells interferes with prereplication complex assembly. J Cell Biol. 2004, 165: 789-800. 10.1083/jcb.200404092PubMed CentralView ArticlePubMedGoogle Scholar
- Mailand N, Bekker-Jensen S, Faustrup H, Melander F, Bartek J, Lukas C, Lukas J: RNF8 ubiquitylates histones at DNA double-strand breaks and promotes assembly of repair proteins. Cell. 2007, 131: 887-900. 10.1016/j.cell.2007.09.040View ArticlePubMedGoogle Scholar
- Wang B, Elledge SJ: Ubc13/Rnf8 ubiquitin ligases control foci formation of the Rap80/Abraxas/Brca1/Brcc36 complex in response to DNA damage. Proc Natl Acad Sci U S A. 2007, 104: 20759-20763. 10.1073/pnas.0710061104PubMed CentralView ArticlePubMedGoogle Scholar
- Kolas NK, Chapman JR, Nakada S, Ylanko J, Chahwan R, Sweeney FD, Panier S, Mendez M, Wildenhain J, Thomson TM, Pelletier L, Jackson SP, Durocher D: Orchestration of the DNA-damage response by the RNF8 ubiquitin ligase. Science. 2007, 318: 1637-1640. 10.1126/science.1150034PubMed CentralView ArticlePubMedGoogle Scholar
- Huen MS, Grant R, Manke I, Minn K, Yu X, Yaffe MB, Chen J: RNF8 transduces the DNA-damage signal via histone ubiquitylation and checkpoint protein assembly. Cell. 2007, 131: 901-914. 10.1016/j.cell.2007.09.041PubMed CentralView ArticlePubMedGoogle Scholar
- Zhao GY, Sonoda E, Barber LJ, Oka H, Murakawa Y, Yamada K, Ikura T, Wang X, Kobayashi M, Yamamoto K, Boulton SJ, Takeda S: A critical role for the ubiquitin-conjugating enzyme Ubc13 in initiating homologous recombination. Mol Cell. 2007, 25: 663-675. 10.1016/j.molcel.2007.01.029View ArticlePubMedGoogle Scholar
- Mendez J, Stillman B: Chromatin association of human origin recognition complex, cdc6, and minichromosome maintenance proteins during the cell cycle: assembly of prereplication complexes in late mitosis. Mol Cell Biol. 2000, 20: 8602-8612. 10.1128/MCB.20.22.8602-8612.2000PubMed CentralView ArticlePubMedGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.